Immunic
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
IMUX Key Statistics
Stock Snapshot
The current Immunic(IMUX) stock price is $9.88, with a market capitalization of 134.58M. The stock trades at a price-to-earnings (P/E) ratio of -1.29.
On 2026-05-04, Immunic(IMUX) stock traded between a low of $9.66 and a high of $10.24. Shares are currently priced at $9.88, which is +2.3% above the low and -3.5% below the high.
The Immunic(IMUX)'s current trading volume is 58.91K, compared to an average daily volume of 383.73K.
In the last year, Immunic(IMUX) shares hit a 52-week high of $15.10 and a 52-week low of $5.06.
In the last year, Immunic(IMUX) shares hit a 52-week high of $15.10 and a 52-week low of $5.06.
IMUX News
LifeSci Capital analyst Sam Slutsky initiated coverage of Immunic (IMUX) with an Outperform rating and $56 price target Unlock hedge fund-level data and powerf...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
(RTTNews) - Immunic, Inc. (IMUX), Tuesday announced the appointment of Michael Panzara, as Chief Medical Officer, succeeding Andreas Muehler, effective April 24...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.